[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Raghav Wadhwa [@raghavwadhwa](/creator/twitter/raghavwadhwa) on x 97K followers Created: 2025-07-17 09:09:32 UTC 🔹Cipla, Dr. Reddy’s Laboratories, Lupin, and Sun Pharma are aggressively advancing generic or novel GLP-1 therapies, with regulatory filings and R&D pipelines targeting both domestic and international markets. XXXXX engagements  **Related Topics** [$drreddyns](/topic/$drreddyns) [dr reddys](/topic/dr-reddys) [$ciplans](/topic/$ciplans) [Post Link](https://x.com/raghavwadhwa/status/1945772849454620958)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Raghav Wadhwa @raghavwadhwa on x 97K followers
Created: 2025-07-17 09:09:32 UTC
🔹Cipla, Dr. Reddy’s Laboratories, Lupin, and Sun Pharma are aggressively advancing generic or novel GLP-1 therapies, with regulatory filings and R&D pipelines targeting both domestic and international markets.
XXXXX engagements
Related Topics $drreddyns dr reddys $ciplans
/post/tweet::1945772849454620958